About Cytoki
Cytoki Leadership
Cytoki’s team of experienced executives combine deep expertise in IL-22 biology, lipidation technology and drug development. They are uniquely positioned to leverage the potential of IL-22 as a new treatment paradigm for serious diseases involving epithelial injury.
Our team
Rasmus Jorgensen, PhD
CEO
Anne Louise Kjølbye, PhD, MBA
Chief Development Officer
Martijn van de Bunt, MD, DPhil
Vice President of Research
Jens Chr. Norrild, PhD
Vice President of CMC
Karsten Skydsgaard, DVM, E*MBA
Head of Non-Clinical Development
Our board
Christian Elling
Chairperson and Managing Partner, Lundbeckfonden BioCapital
Karen Wagner
Managing Partner, Ysios Capital
Dani Bach
Partner, +ND Capital
Amanda Chaperot
Partner, Seventure Partners
Our investors
